01 1Amsa
01 1GLIPIZIDE
01 1Italy
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-03-21
Pay. Date : 2013-09-23
DMF Number : 13101
Submission : 1998-07-30
Status : Active
Type : II
20
Amsa Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is GLIPIZIDE, with a corresponding US DMF Number 13101.
Remarkably, this DMF maintains an Active status since its submission on July 30, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 21, 2014, and payment made on September 23, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
